Guanxiong Ding

914 total citations
40 papers, 691 citations indexed

About

Guanxiong Ding is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Guanxiong Ding has authored 40 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Guanxiong Ding's work include Prostate Cancer Treatment and Research (9 papers), Renal cell carcinoma treatment (8 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Guanxiong Ding is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Renal cell carcinoma treatment (8 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Guanxiong Ding collaborates with scholars based in China, United States and Canada. Guanxiong Ding's co-authors include Qiang Ding, Chenchen Feng, Haowen Jiang, Lujia Wang, Zhong Wu, Jianqing Wang, Zhongwen Zhou, Shijun Tong, Jun Liu and Jianfeng Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Guanxiong Ding

39 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guanxiong Ding China 17 364 213 189 178 139 40 691
Nilay Patel United Kingdom 10 521 1.4× 194 0.9× 145 0.8× 136 0.8× 141 1.0× 33 720
Nicholas B. Shannon Singapore 14 258 0.7× 164 0.8× 116 0.6× 185 1.0× 255 1.8× 41 677
Cristina López-Blau Spain 4 451 1.2× 122 0.6× 98 0.5× 186 1.0× 96 0.7× 5 766
Chuanming Zheng China 16 245 0.7× 108 0.5× 194 1.0× 194 1.1× 150 1.1× 56 639
Elisabeth Smolle Austria 12 329 0.9× 154 0.7× 237 1.3× 146 0.8× 73 0.5× 21 639
Tamara Aleksic United Kingdom 15 454 1.2× 98 0.5× 219 1.2× 245 1.4× 130 0.9× 18 786
Frédéric Commo France 13 247 0.7× 226 1.1× 171 0.9× 273 1.5× 104 0.7× 16 774
Peter Choyke United States 12 272 0.7× 133 0.6× 277 1.5× 212 1.2× 207 1.5× 20 649
Yota Yasumizu Japan 18 419 1.2× 367 1.7× 180 1.0× 322 1.8× 102 0.7× 78 927
Daizo Oka Japan 13 255 0.7× 172 0.8× 129 0.7× 129 0.7× 128 0.9× 23 567

Countries citing papers authored by Guanxiong Ding

Since Specialization
Citations

This map shows the geographic impact of Guanxiong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanxiong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanxiong Ding more than expected).

Fields of papers citing papers by Guanxiong Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanxiong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanxiong Ding. The network helps show where Guanxiong Ding may publish in the future.

Co-authorship network of co-authors of Guanxiong Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Guanxiong Ding. A scholar is included among the top collaborators of Guanxiong Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanxiong Ding. Guanxiong Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ni, Yi, et al.. (2023). Significance of PBRM1 mutation in disease progress and drug selection in clear cell renal cell carcinoma. Biotechnology and Genetic Engineering Reviews. 40(4). 3901–3915. 1 indexed citations
3.
Ding, Guanxiong, Qing Zhang, Kwok Yan Li, et al.. (2021). ZBTB38 suppresses prostate cancer cell proliferation and migration via directly promoting DKK1 expression. Cell Death and Disease. 12(11). 998–998. 11 indexed citations
4.
Sun, Jian, Huihui Zhou, Fei Wang, et al.. (2020). HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer. Journal of Cellular and Molecular Medicine. 24(24). 14539–14548. 18 indexed citations
5.
Wang, Jianqing, Chenxi He, Peng Gao, et al.. (2019). HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer. Oncogene. 39(6). 1335–1346. 35 indexed citations
6.
Liu, Shenghua, Guanxiong Ding, Zhongwen Zhou, & Chenchen Feng. (2018). β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion. OncoTargets and Therapy. Volume 11. 2029–2036. 20 indexed citations
7.
Feng, Chenchen, Guanxiong Ding, Qiang Ding, & Hui‐Ju Wen. (2018). Overexpression of low density lipoprotein receptor-related protein 1 (LRP1) is associated with worsened prognosis and decreased cancer immunity in clear-cell renal cell carcinoma. Biochemical and Biophysical Research Communications. 503(3). 1537–1543. 15 indexed citations
8.
Zhao, Chunchun, et al.. (2018). EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis. Journal of Cancer. 9(20). 3787–3796. 31 indexed citations
9.
Wang, Lujia, Chenchen Feng, Guanxiong Ding, et al.. (2017). Association Study of Reported Significant Loci at 5q35.3, 7p14.3, 13q14.1 and 16p12.3 with Urolithiasis in Chinese Han Ethnicity. Scientific Reports. 7(1). 45766–45766. 8 indexed citations
10.
Wang, Lujia, Chenchen Feng, Peng Gao, et al.. (2016). Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy. International Urology and Nephrology. 48(4). 495–501. 21 indexed citations
11.
Feng, Chenchen, Yang Sun, Guanxiong Ding, et al.. (2015). PI3Kβ Inhibitor TGX221 Selectively Inhibits Renal Cell Carcinoma Cells with Both VHL and SETD2 mutations and Links Multiple Pathways. Scientific Reports. 5(1). 9465–9465. 40 indexed citations
12.
Feng, Chenchen, Guanxiong Ding, Haowen Jiang, Qiang Ding, & Hui Wen. (2014). Loss of MLH1 confers resistance to PI3Kβ inhibitors in renal clear cell carcinoma with SETD2 mutation. Tumor Biology. 36(5). 3457–3464. 22 indexed citations
13.
14.
Xu, Hua, Shanhua Mao, Guanxiong Ding, Qiang Ding, & Haowen Jiang. (2013). Diabetes Mellitus Reduces Prostate Cancer Risk - No Function of Age at Diagnosis or Duration of Disease. Asian Pacific Journal of Cancer Prevention. 14(1). 441–447. 11 indexed citations
15.
Xu, Hua, Haowen Jiang, Guanxiong Ding, et al.. (2013). Diabetes mellitus and prostate cancer risk of different grade or stage: A systematic review and meta-analysis. Diabetes Research and Clinical Practice. 99(3). 241–249. 49 indexed citations
16.
Ding, Guanxiong, Chenchen Feng, Haowen Jiang, et al.. (2013). Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition. PLoS ONE. 8(10). e77400–e77400. 24 indexed citations
17.
Wang, Lujia, Chenchen Feng, Guanxiong Ding, et al.. (2013). Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer. Tumor Biology. 35(4). 2989–2995. 32 indexed citations
18.
Wen, Hui, Chenchen Feng, Guanxiong Ding, et al.. (2012). Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2. Annals of Diagnostic Pathology. 17(3). 259–264. 30 indexed citations
19.
Ding, Guanxiong, Ninghong Song, Chenchen Feng, et al.. (2012). Is There an Association between Advanced Stage of Renal Cell Carcinoma and Paraneoplastic Syndrome?. Medical Principles and Practice. 21(4). 370–374. 12 indexed citations
20.
Ding, Guanxiong, Fang Liu, Baixin Shen, et al.. (2012). The Association Between Polymorphisms in Prooxidant or Antioxidant Enzymes (Myeloperoxidase, SOD2, and CAT) and Genes and Prostate Cancer Risk in the Chinese Population of Han Nationality. Clinical Genitourinary Cancer. 10(4). 251–255. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nilay Patel Breakdown of academic impact, for papers by Nicholas B. Shannon Breakdown of academic impact, for papers by Cristina López-Blau Breakdown of academic impact, for papers by Chuanming Zheng Breakdown of academic impact, for papers by Elisabeth Smolle Breakdown of academic impact, for papers by Tamara Aleksic Breakdown of academic impact, for papers by Frédéric Commo Breakdown of academic impact, for papers by Peter Choyke Breakdown of academic impact, for papers by Yota Yasumizu Breakdown of academic impact, for papers by Daizo Oka
Rankless by CCL
2026